# Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis

> **NCT00447837** · PHASE2 · COMPLETED · sponsor: **Naryx Pharma** · enrollment: 180 (actual)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** SPRC-AB01

## Key facts

- **NCT ID:** NCT00447837
- **Lead sponsor:** Naryx Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2008-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447837, "Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00447837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*